The rapid expansion of longevity, regenerative medicine, and preventive health has created a new category of healthcare delivery, one that operates at the intersection of advanced clinical practice, innovation, hospitality, and real estate–based health ecosystems.
Global Healthcare Accreditation (GHA) developed the Longevity & Regenerative Medicine Accreditation Program to provide an independent, internationally aligned framework for organizations operating in this evolving space, ensuring that innovation scales responsibly, ethically, and with appropriate governance.
This pioneering accreditation supports organizations delivering advanced longevity and regenerative services while strengthening patient trust, operational discipline, and long-term credibility as visibility and complexity increase.
The Longevity & Regenerative Medicine Accreditation is designed for organizations operating at the highest levels of complexity and visibility, including:
This program applies to both clinical environments and non-traditional care settings where medical services intersect with hospitality, residential living, and lifestyle infrastructure.
Longevity and regenerative medicine are no longer niche or experimental categories. They represent one of the fastest-growing segments of the global health and wellness economy, driven by demographic shifts, advances in diagnostics and cell-based therapies, and rising demand for preventive, personalized care.
According to the Global Wellness Institute, the global wellness economy reached $6.8 trillion in 2024 and is projected to grow to $9.7 trillion by 2029, outpacing global GDP growth. Within this ecosystem, longevity-focused services, including preventive medicine, regenerative therapies, wellness tourism, and wellness-anchored real estate—are among the fastest-expanding sectors.
This growth is being fueled by:
As longevity medicine scales faster than traditional healthcare systems and regulatory models, organizations face increased risk, visibility, and scrutiny.
GHA accreditation helps organizations:
The accreditation framework evaluates how organizations manage governance, risk, and patient experience across the longevity care continuum, including:
The objective is not to standardize innovation—but to ensure it is delivered within a responsible, defensible, and internationally credible operational framework.
Organizations engaging with GHA benefit from:
GHA serves as an independent trust layer—allowing innovators, clinicians, developers, and operators to advance longevity, while GHA ensures the operational foundation remains credible as the field grows.
To learn more about the Longevity & Regenerative Medicine Accreditation Program, or to explore how accreditation may support your organization’s growth strategy, please contact Global Healthcare Accreditation.